[Severe bacterial infections acquired during respiratory resuscitation of the newborn].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000985:Antisepsis; D002404:Catheterization / Q000009:adverse effects; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases; D007362:Intensive Care Units; D007442:Intubation, Intratracheal / Q000009:adverse effects; D007565:Jaundice / Q000175:diagnosis; D008171:Lung Diseases / Q000175:diagnosis; D009461:Neurologic Manifestations; D010102:Oxygen Inhalation Therapy; D011379:Prognosis; D012127:Respiratory Distress Syndrome, Newborn / Q000150:complications; D012151:Resuscitation / Q000009:adverse effects*; D018805:Sepsis / Q000175:diagnosis / Q000382:microbiology
D000900:Anti-Bacterial Agents
Les infections bactériennes graves acquises au cours de la réanimation respiratoire du nouveau-né.